Cargando…
Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy
Neutrophil-to-lymphocyte ratio (NLR), a simple marker of systemic inflammatory response, has been demonstrated as an independent prognosticator for some solid malignancies, including prostate cancer. In the present study, we evaluated the role of NLR in men who underwent prostate needle biopsy for t...
Autores principales: | Kawahara, Takashi, Fukui, Sachi, Sakamaki, Kentaro, Ito, Yusuke, Ito, Hiroki, Kobayashi, Naohito, Izumi, Koji, Yokomizo, Yumiko, Miyoshi, Yasuhide, Makiyama, Kazuhide, Nakaigawa, Noboru, Yamanaka, Takeharu, Yao, Masahiro, Miyamoto, Hiroshi, Uemura, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741667/ https://www.ncbi.nlm.nih.gov/pubmed/26359354 |
Ejemplares similares
-
Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy
por: Kawahara, Takashi, et al.
Publicado: (2016) -
Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
por: Kawahara, Takashi, et al.
Publicado: (2016) -
The impact of gender difference on operative time in laparoscopic partial nephrectomy for T1 renal tumor and the utility of retroperitoneal fat thickness as a predictor of operative time
por: Ito, Hiroki, et al.
Publicado: (2016) -
The Pretherapeutic Neutrophil-to-Lymphocyte Ratio for Docetaxel-Based Chemotherapy Is Useful for Predicting the Prognosis of Japanese Patients with Castration-Resistant Prostate Cancer
por: Tatenuma, Tomoyuki, et al.
Publicado: (2019) -
Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy
por: Ohtake, Shinji, et al.
Publicado: (2016)